Piper Sandler downgraded Olin (OLN) to Neutral from Overweight with a price target of $33, down from $41. The challenges Olin faces due to the difficult economic conditions in Europe and Asia will not be able to be offset by other improvements in the U.S. markets in 2025, the analyst tells investors in a research note. The firm says epoxy markets will likely remain “problematic” as will the recovery of Winchester earnings as downstream customers destock product at least through the first half of 2025. Olin will also have to deal with the closure of the Dow propylene oxide facility, which will probably cause some disruption in the chloralkali markets, adds Piper.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OLN:
- Olin price target lowered to $34 from $40 at BofA
- Buy Rating for Olin: Earnings Recovery and Strategic Positioning Amidst Market Challenges
- Olin Announces New Ammunition Facility with U.S. Army
- Olin price target lowered to $34 from $44 at BMO Capital
- Olin price target lowered to $28 from $31 at Morgan Stanley